Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis

BACKGROUND: Pemetrexed is used for the treatment for non-small cell lung cancer and mesothelioma. Patients with renal impairment are withheld treatment with this drug as it is unknown what dose is well tolerated in this population. OBJECTIVE: The purpose of our study was to investigate the pharmacok...

Descripción completa

Detalles Bibliográficos
Autores principales: de Rouw, Nikki, Boosman, Rene J., Huitema, Alwin D. R., Hilbrands, Luuk B., Svensson, Elin M., Derijks, Hieronymus J., van den Heuvel, Michel M., Burger, David M., ter Heine, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113206/
https://www.ncbi.nlm.nih.gov/pubmed/33420970
http://dx.doi.org/10.1007/s40262-020-00972-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113206/
https://www.ncbi.nlm.nih.gov/pubmed/33420970
http://dx.doi.org/10.1007/s40262-020-00972-1

Ejemplares similares